Los puntos clave no están disponibles para este artículo en este momento.
Why are there so few effective catalysts in the multitude of new designed supramolecular arrays? How can we apparently understand so much and yet fail to produce even rudimentary catalysts reliably? This article highlights some recent successes, explores the reasons for failure, and points to some new directions for the future, such as the question posed on the right.
Jeremy K. M. Sanders (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: